Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Find Your Internal Culinary expert: Cooking Strategies and Recipes - 2The Most Compelling Innovation Developments Somewhat recently
- 34 astronauts depart ISS, leaving behind just 3 crewmates to staff the orbiting lab
- 4James Webb Space Telescope watches 'Jekyll and Hyde' galaxy shapeshift into a cosmic monster
- 5The Best Internet Mastering Stages for Expertise Improvement
- 9 African migrants died in freezing temperatures near Morocco-Algeria border
- The most effective method to Amplify Profits from Gold Speculation: Systems and Tips
- I’m a dad to an autistic child. Here’s how you can make the holidays easier for all of us.
- CDC clarifies stance on vaccines and autism, stating no evidence supports the link
- NASA loses contact with its Maven spacecraft orbiting Mars for the past decade
- The Electric Bicycle Americans Can Confide in 2024
- Executed Iranian nuclear scientist confessed to aiding Israel after torture, threats against mother
- Defence chiefs of Thailand and Cambodia to discuss ceasefire
- Watching ‘Home Alone’ with the kids this holiday season? Brace yourself for '6-7.'
